ERIN SWAILES: Open Payments
NPI 1932192390 · HIAWATHA, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$371 in 21 payments from 9 companies in 2025. Trend: 2023 $1,137 · 2024 $942 · 2025 $371
Food & beverage: $371
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 5 | $91 |
| Novo Nordisk Inc | 4 | $71 |
| Lilly USA, LLC | 3 | $52 |
| Abbott Laboratories | 2 | $41 |
| Exact Sciences Corporation | 2 | $34 |
| AstraZeneca Pharmaceuticals LP | 2 | $28 |
| PFIZER INC. | 1 | $19 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $18 |
| Paratek Pharmaceuticals, Inc. | 1 | $18 |
Products named: VRAYLAR, FREESTYLE LIBRE 3, Ozempic, Wegovy, QULIPTA, JARDIANCE, MOUNJARO, PAXLOVID.
Industry payments across IA — which companies pay providers there.
